Source - SMW
Beaufort Securities today upgrades its investment rating on GlaxoSmithKline PLC (LON:GSK) to buy (from long term buy) and raised its price target to 1500p (from 1450p).



Broker Forecasts data provided by www.sharesmagazine.co.uk

Related Charts

GlaxoSmithKline (GSK)

+0.40p (+0.03%)
delayed 05:00AM